Effect of ursodeoxycholic acid on liver markers: A systematic review and meta‐analysis of randomized placebo‐controlled clinical trials-Reference-Cited by-同舟云学术

Effect of ursodeoxycholic acid on liver markers: A systematic review and meta‐analysis of randomized placebo‐controlled clinical trials

Published:2020-04-27 Issue:8 Volume:86 Page:1476-1488
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Simental‐Mendía Mario¹,Sánchez‐García Adriana²,Simental‐Mendía Luis E.³^ORCID

Affiliation:

1. Department of Orthopedics and Traumatology, Hospital Universitario “Dr. José E. González”, Facultad de MedicinaUniversidad Autónoma de Nuevo León Monterrey NL Mexico

2. Endocrinology Division, Hospital Universitario “Dr. José E. González”, Facultad de MedicinaUniversidad Autónoma de Nuevo León Monterrey NL Mexico

3. Unidad de Investigación Biomédica, Delegación DurangoInstituto Mexicano del Seguro Social Mexico

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14311

Reference54 articles.

1. Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications

2. Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited

3. Use of ursodeoxycholic acid in liver diseases

4. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action

5. Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis;Seminars in Liver Disease;2024-02

2. An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-11-10

3. Dietary factors in nonalcoholic fatty liver disease: impacts on human and animal health - a review;Animal Science Papers and Reports;2023-09-01

4. Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis;Journal of Personalized Medicine;2023-07-24

5. Protective effect of ursodeoxycholic acid and resveratrol against tacrolimus induced hepatotoxicity;Biotechnic & Histochemistry;2023-06-28